Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Gains from Investment Securities (2023 - 2025)

Profound Medical has reported Gains from Investment Securities over the past 3 years, most recently at $92900.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $92900.0 for Q4 2025, down 24.75% from a year ago — trailing twelve months through Dec 2025 was $92900.0 (down 24.75% YoY), and the annual figure for FY2025 was $92900.0, down 24.75%.
  • Gains from Investment Securities for Q4 2025 was $92900.0 at Profound Medical, down from $234573.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for PROF hit a ceiling of $2.1 million in Q2 2025 and a floor of $14000.0 in Q1 2024.
  • Median Gains from Investment Securities over the past 3 years was $160000.0 (2024), compared with a mean of $710704.7.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 91.63% in 2024 and later surged 14978.83% in 2025.
  • Profound Medical's Gains from Investment Securities stood at $1.5 million in 2023, then plummeted by 91.63% to $123456.0 in 2024, then dropped by 24.75% to $92900.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $92900.0 (Q4 2025), $234573.0 (Q3 2025), and $2.1 million (Q2 2025) per Business Quant data.